Redwood City, CA, United States of America

Daniel G M Shore


Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Discovering Innovations: The Contributions of Inventor Daniel G. M. Shore

Introduction

Daniel G. M. Shore is an innovative inventor based in Redwood City, California, who has made significant contributions in the field of pharmaceutical development. With a total of two patents to his name, Shore's work primarily reflects on the enhancement of medical treatments through innovative compounds and methods.

Latest Patents

Daniel Shore's latest patents focus on the development of substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases. The first patent outlines compounds of formula (I), detailed with specific groups (R, R, R, R, R) as defined in the document, and their salts. These inhibitors are particularly useful in treating diseases that respond to the inhibition of Janus kinase activity. Additionally, the patents describe pharmaceutical compositions incorporating these JAK inhibitors along with a pharmaceutically acceptable carrier, adjuvant, or vehicle, highlighting methods of treating or alleviating conditions associated with JAK kinase inhibition.

Career Highlights

Daniel Shore has established his career at Genentech, Inc., a leading biotechnology company recognized for its pioneering work in medicine. Throughout his tenure, he has contributed to various projects aimed at advancing therapeutic options and improving patient outcomes.

Collaborations

At Genentech, Shore collaborates with esteemed colleagues, including Mark Edward Zak and Naomi S. Rajapaksa. Together, they foster a collaborative environment conducive to creativity and innovation, driving forward the development of novel medical treatments.

Conclusion

In conclusion, Daniel G. M. Shore exemplifies the spirit of innovation within the pharmaceutical field. His contributions through patents focused on JAK kinase inhibitors are significant, promising advancements in the treatment of various conditions. As he continues his work at Genentech, his commitment to innovation stands to impact the lives of many patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…